Inflammation in Tumorigenesis and Cancer Treatment: From Molecular Mechanisms to Personalized Therapeutic Strategies explores the pivotal role of inflammation in cancer. It uncovers the molecular dialogue between inflammatory factors and tumor cells, illuminating pathways that drive oncogenesis and metastasis. Highlighting the rapid pace of discovery, the book bridges the gap by translating complex data into actionable clinical strategies, catering to students and professionals and addressing personalized medicine. Early chapters focus on the fundamental concepts of inflammation in cancer and recent advances in research, while also covering the impact of inflammatory mediators on signaling pathways and oncogenesis.
Other sections explore therapeutic strategies targeting inflammatory pathways and the role of immunometabolism and discuss biomarker discovery and personalized treatment plans. The final section examines the tumor microenvironment, the microbiome's role, and the intersection of immunotherapy and inflammation. The book offers numerous benefits to its audience. For scientists and researchers, it provides cutting-edge knowledge to inspire new research directions and foster interdisciplinary collaboration while serving as a valuable educational tool for the next generation of researchers.
1. Chapter 1. Introduction - p. 3 2. Chapter 2. Emerging technologies and future research directions in inflammation and cancer research - p. 19 3. Section II: Micro/nano-modulation of cancer inflammation and immunometabolism - p. S37 4. Chapter 3. Recent advances and future research directions in the crosstalk between inflammation and tumors - p. 39 5. Chapter 4. Micro/nano-modulation of inflammatory signaling pathways in cancer - p. 65 6. Section III: Translational research and therapeutic targets - p. S99 7. Chapter 5. Micro/nanoplatforms for modulating programmed cell death and tumor inflammation - p. 101 8. Chapter 6. Micro/nano-enabled immunometabolic regulation in inflammatory tumors - p. 127 9. Section IV: Biomarkers and personalized medicine - p. S165 10. Chapter 7. Biomarker discovery and validation in inflammatory cancer research - p. 167 11. Chapter 8. Personalized medicine utilizing biomarkers - p. 193 12. Section V: Clinical implications and therapeutic strategies - p. S225 13. Chapter 9. Inflammation and tumor microenvironment - p. 227 14. Chapter 10. Antineoplastic potential of nonsteroidal antiinflammatory drugs - p. 251 15. Chapter 11. Immunotherapy and inflammation management - p. 271 16. Index - p. 285
Inflammation in Tumorigenesis and Cancer Treatment: From Molecular Mechanisms to Personalized Therapeutic Strategies explores the pivotal role of inflammation in cancer. It uncovers the molecular dialogue between inflammatory factors and tumor cells, illuminating pathways that drive oncogenesis and metastasis. Highlighting the rapid pace of discovery, the book bridges the gap by translating complex data into actionable clinical strategies, catering to students and professionals and addressing personalized medicine. Early chapters focus on the fundamental concepts of inflammation in cancer and recent advances in research, while also covering the impact of inflammatory mediators on signaling pathways and oncogenesis.
Other sections explore therapeutic strategies targeting inflammatory pathways and the role of immunometabolism and discuss biomarker discovery and personalized treatment plans. The final section examines the tumor microenvironment, the microbiome's role, and the intersection of immunotherapy and inflammation. The book offers numerous benefits to its audience. For scientists and researchers, it provides cutting-edge knowledge to inspire new research directions and foster interdisciplinary collaboration while serving as a valuable educational tool for the next generation of researchers.
1. Chapter 1. Introduction - p. 3 2. Chapter 2. Emerging technologies and future research directions in inflammation and cancer research - p. 19 3. Section II: Micro/nano-modulation of cancer inflammation and immunometabolism - p. S37 4. Chapter 3. Recent advances and future research directions in the crosstalk between inflammation and tumors - p. 39 5. Chapter 4. Micro/nano-modulation of inflammatory signaling pathways in cancer - p. 65 6. Section III: Translational research and therapeutic targets - p. S99 7. Chapter 5. Micro/nanoplatforms for modulating programmed cell death and tumor inflammation - p. 101 8. Chapter 6. Micro/nano-enabled immunometabolic regulation in inflammatory tumors - p. 127 9. Section IV: Biomarkers and personalized medicine - p. S165 10. Chapter 7. Biomarker discovery and validation in inflammatory cancer research - p. 167 11. Chapter 8. Personalized medicine utilizing biomarkers - p. 193 12. Section V: Clinical implications and therapeutic strategies - p. S225 13. Chapter 9. Inflammation and tumor microenvironment - p. 227 14. Chapter 10. Antineoplastic potential of nonsteroidal antiinflammatory drugs - p. 251 15. Chapter 11. Immunotherapy and inflammation management - p. 271 16. Index - p. 285
